Avenue Therapeutics, Inc. (ATXI)
NASDAQ: ATXI · Real-Time Price · USD
2.060
+0.080 (4.04%)
Nov 21, 2024, 2:45 PM EST - Market open
Avenue Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 4.74 | 4.18 | 5.35 | 2.48 | 2.35 | 3.07 | |
| Research & Development | 7.06 | 10.36 | 2.7 | 1.25 | 2.87 | 23.19 | |
| Operating Expenses | 11.81 | 14.54 | 8.04 | 3.74 | 5.21 | 26.27 | |
| Operating Income | -11.81 | -14.54 | -8.04 | -3.74 | -5.21 | -26.27 | |
| Interest & Investment Income | 0.51 | 0.13 | 0.02 | 0.01 | 0.06 | 0.36 | |
| Other Non Operating Income (Expenses) | 1.78 | 3.93 | 4.42 | - | - | - | |
| EBT Excluding Unusual Items | -9.52 | -10.49 | -3.6 | -3.73 | -5.15 | -25.91 | |
| Pretax Income | -9.52 | -10.49 | -3.6 | -3.73 | -5.15 | -25.91 | |
| Earnings From Continuing Operations | -9.52 | -10.49 | -3.6 | -3.73 | -5.15 | -25.91 | |
| Minority Interest in Earnings | 0.05 | 0.11 | 0.05 | - | - | - | |
| Net Income | -9.47 | -10.38 | -3.55 | -3.73 | -5.15 | -25.91 | |
| Net Income to Common | -9.47 | -10.38 | -3.55 | -3.73 | -5.15 | -25.91 | |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 933.39% | 384.71% | 92.83% | 2.98% | 4.99% | - | |
| EPS (Basic) | -10.63 | -73.48 | -121.92 | -246.94 | -351.08 | -1853.88 | |
| EPS (Diluted) | -20.51 | -73.48 | -121.92 | -246.94 | -351.08 | -1853.88 | |
| Free Cash Flow | -10.59 | -9.45 | -7.6 | -3.75 | -4.61 | -26.26 | |
| Free Cash Flow Per Share | -11.88 | -66.92 | -260.72 | -248.20 | -314.41 | -1879.00 | |
| EBIT | -11.81 | -14.54 | -8.04 | -3.74 | -5.21 | -26.27 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.